The drug company Prinstin Pharmaceuticals has announced
that eight lots of Irbesatan blood pressure medication have been recalled after testing indicates the meds contain trace amounts of a cancer-causing material. In the announcement, the company says one lot of Irbesartan tablets and seven lots of Irbesartan HCTZ tablets are being recalled.
The news release from Prinstin Pharmaceuticals says the medication contained unacceptable levels of Nitrosodiethylamine, a likely cancer causing agent. The ingredients for the medication were manufactured by China's Zheijiang Huahai Pharmaceuticals. That company has been linked to several recalls of regularly-prescribed blood pressure drugs since mid-2018.
For more information and to see a list of the lots that have been recalled, from the FDA, click here.
At the law offices of T. Verner Smith, we represent clients who have suffered personal injury due to the negligence of another. These types of lawsuits not only provide necessary compensation for those who were wrongfully hurt in an accident, but also creates an environment of caution leading to higher safety standards for all. Contact us for a free consultation at (731) 423-1888, (901) 730-4567, or (615) 371-6136.